| Evaluation of 611 in Chinese Adults With Moderate to Severe Atopic Dermatitis (NCT05544591) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2022-10-26 |
| Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients (NCT05377034) | National Cancer Centre, Singapore | 2022-10-26 |
| Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT05479994) | BeiGene | 2022-10-25 |
| The Effect of Intrawound Vancomycin Powder on Surgical Site Infection in Inguinal Lymph Node Dissection (NCT05625373) | Women and Infants Hospital of Rhode Island | 2022-10-25 |
| Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD (NCT05507242) | Asger Sverrild | 2022-10-25 |
| A Study to Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis (NCT05531682) | Huabo Biopharm Co., Ltd. | 2022-10-25 |
| Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study) (NCT05331144) | Rong Zhang | 2022-10-25 |
| A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Tolerant Users Undergoing Surgery to Reduce Post-operative Opioid Use (NCT05589857) | M.D. Anderson Cancer Center | 2022-10-25 |
| A Study of TNM001 in Chinese Healthy Preterm and Term Infants (NCT05630573) | Zhuhai Trinomab Pharmaceutical Co., Ltd. | 2022-10-25 |
| Evaluation of Intubation Conditions Following BX1000 or Rocuronium in Subjects Undergoing Surgery (NCT05687253) | Baudax Bio | 2022-10-25 |
| Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients (NCT05762900) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2022-10-25 |
| Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC) (NCT03454750) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2022-10-25 |
| A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain (NCT05560646) | Organon and Co | 2022-10-25 |
| Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH (NCT05339087) | Heidelberg University | 2022-10-24 |
| A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX) (NCT05540860) | Edgewise Therapeutics, Inc. | 2022-10-24 |
| PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma (NCT05286814) | National Cancer Institute (NCI) | 2022-10-24 |
| Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease (NCT05521672) | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 2022-10-24 |
| Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia (NCT04527224) | Nature Cell Co. Ltd. | 2022-10-24 |
| Study of The Second-line Treatment of Advanced Gastric / Gastroesophageal Junction Adenocarcinoma With Envafolimab and Lenvatinib Combined With Paclitaxel-albumin (NCT06030934) | Fudan University | 2022-10-24 |
| Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older (NCT05726084) | St. Petersburg Research Institute of Vaccines and Sera | 2022-10-24 |
| Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation (NCT05358249) | Novartis Pharmaceuticals | 2022-10-24 |
| Mosunetuzumab and Polatuzumab Vedotin for Untreated Follicular Lymphoma (NCT05410418) | Washington University School of Medicine | 2022-10-24 |
| A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Patients With Pulmonary Hypertension After Cardiopulmonary Bypass Surgery (NCT05699486) | Attgeno AB | 2022-10-23 |
| Modified TBF Regimen as Conditioning Regimen Prior to Allo-HSCT for T-ALL/LBL (NCT05598593) | First Affiliated Hospital of Zhejiang University | 2022-10-23 |
| The Use of Eltrombopag Post HSCT in BMFD (NCT05466201) | The First Affiliated Hospital of Soochow University | 2022-10-22 |
| A Proof of Concept, Phase 2, Double-blind, Randomized Trial With d-Methadone Product Versus Placebo (NCT04145674) | Mauro Manconi | 2022-10-22 |
| Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion (NCT05992220) | Asan Medical Center | 2022-10-22 |
| Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) (NCT05485961) | CSL Behring | 2022-10-21 |
| Surgical Pembro +/- Olaparib w TMZ for rGBM (NCT05463848) | L. Nicolas Gonzalez Castro, MD, PhD | 2022-10-21 |
| HEC169096 in Participants With Advanced Solid Tumors (NCT05451602) | Sunshine Lake Pharma Co., Ltd. | 2022-10-21 |
| Pediatric GVHD Low Risk Steroid Taper Trial (NCT05090384) | John Levine | 2022-10-20 |
| A Phase II Clinical Trial to Evaluate HLX208 in Advanced Solid Tumor Patients With BRAF V600 Mutation (NCT05528406) | Shanghai Henlius Biotech | 2022-10-20 |
| A Study of DS-1211b in Individuals With PseudoXanthoma Elasticum (NCT05569252) | Daiichi Sankyo | 2022-10-20 |
| Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management (NCT05561309) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2022-10-20 |
| High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver Disease (NCT05578404) | Tanta University | 2022-10-20 |
| A Study to Explore the Efficacy of Alprostadil Liposomes Injection in the Prevention of CI-AKI (NCT05475717) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2022-10-20 |
| Radiotherapy With Tislelizumab in Patients With Recurrent Head & Neck Cancer (NCT05595590) | Tianjin Medical University Cancer Institute and Hospital | 2022-10-20 |
| Turmeric Gel as Alternative Non-vital Pulpotomy Medicament in Primary Teeth (NCT05801354) | University of Health Sciences Lahore | 2022-10-20 |
| A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory (NCT05581875) | Hellenic Society of Hematology | 2022-10-20 |
| The Effects of Glucagon on Hepatic Metabolism (NCT05500586) | Adrian Vella | 2022-10-20 |
| Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast Cancer (NCT05577442) | Peking University Cancer Hospital & Institute | 2022-10-20 |
| Allium Sativum Oil and Turmeric Gel as Alternative Non-vital Pulpotomy Medicaments in Primary Teeth. (NCT05819970) | University of Health Sciences Lahore | 2022-10-20 |
| Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer (NCT05869123) | Peking Union Medical College Hospital | 2022-10-20 |
| Acute Effects of Ketone Supplement on Responses to Alcohol Challenge in Healthy Volunteers (NCT05551754) | University of Pennsylvania | 2022-10-20 |
| Allium Sativum Oil as Alternative Non-vital Pulpotomy Medicament in Primary Teeth (NCT05801367) | University of Health Sciences Lahore | 2022-10-20 |
| A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)] (NCT05565742) | Eli Lilly and Company | 2022-10-20 |
| Silodosin in Management of Lower Ureteral Stones (NCT06381206) | Syrian Private University | 2022-10-20 |
| SRT in Combination With Pembrolizumab in Patients With Recurrent Prostate Cancer After Radical Prostatectomy (NCT04931979) | Prof. Dr. med. Christian Gratzke | 2022-10-20 |
| Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease (NCT05514548) | Inversago Pharma Inc. | 2022-10-19 |
| Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma (NCT04930653) | City of Hope Medical Center | 2022-10-19 |
| Clinical Trial to Evaluate the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee (NCT05618782) | Levicept | 2022-10-19 |
| Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery (NCT04991025) | Memorial Sloan Kettering Cancer Center | 2022-10-19 |
| Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke (NCT05585606) | Silver Creek Pharmaceuticals | 2022-10-19 |
| Epirubicin for the Treatment of Sepsis & Septic Shock (NCT05033808) | Jena University Hospital | 2022-10-19 |
| A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir (NCT05567952) | Pfizer | 2022-10-19 |
| Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg Vs Placebo As Adjuvant Treatment in Chronic Migraine - (NCT04989413) | Hospital Israelita Albert Einstein | 2022-10-18 |
| Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL (NCT05641428) | University Medical Center Groningen | 2022-10-18 |
| TERPS Trial for de Novo Oligometastic Prostate Cancer (NCT05223803) | University of Maryland, Baltimore | 2022-10-18 |
| Efficacy and Safety of Inotuzumab Ozogamicin in Treating Adult Patients With Ph Negative ALL With Minimal Residual Disease Positive After Induction Chemotherapy (NCT05456698) | Institute of Hematology & Blood Diseases Hospital, China | 2022-10-18 |
| A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma (NCT05372354) | Bristol-Myers Squibb | 2022-10-18 |
| A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008) (NCT05508867) | Merck Sharp & Dohme LLC | 2022-10-18 |
| Safety and Dosage of a Computerized Cognitive Training Program for Cognitive Dysfunction After COVID-19 (NCT05582603) | Universidad Antonio de Nebrija | 2022-10-18 |
| A Study Comparing Rituximab/Bendamustin(RB) Alternating With Rituximab/Bendamustin/Cytarabin(RBAC) With RB Therapy in Elderly Patients With Mentle Cell Lymphoma (NCT05245656) | Kim, Seok Jin | 2022-10-18 |
| Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma (NCT05595447) | Hospital Regional de Alta Especialidad del Bajio | 2022-10-18 |
| Reduce Crohn's-Associated Diarrhea With Sodium Channel Therapy (NCT04456517) | Vanderbilt University Medical Center | 2022-10-18 |
| Vascular Impact of Dapagliflozin in CKD Patients (DAPAVASC) (NCT04930549) | University Hospital, Rouen | 2022-10-18 |
| Neoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation Therapy (NCT05137899) | Ontario Clinical Oncology Group (OCOG) | 2022-10-18 |
| GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma (NCT05668884) | Fudan University | 2022-10-18 |
| A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma (NCT05535244) | Hoffmann-La Roche | 2022-10-17 |
| A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer (NCT05420948) | University of Chicago | 2022-10-17 |
| Sotagliflozin Safety and Tolerability Among Renal Transplant Recipients (NCT05405556) | Martina McGrath, MD | 2022-10-17 |
| Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer (NCT05620134) | Salubris Biotherapeutics Inc | 2022-10-17 |
| Gametocytocidal and Transmission-blocking Efficacy of ASAQ and ALAQ With or Without PQ in Mali (NCT05550909) | London School of Hygiene and Tropical Medicine | 2022-10-17 |
| Study for Adolescents and Adults With Ornithine Transcarbamylase Deficiency to Evaluate Safety and Tolerability of ARCT-810 (NCT05526066) | Arcturus Therapeutics, Inc. | 2022-10-17 |
| HCW9218 for Advanced Pancreatic Cancer (NCT05304936) | ImmunityBio, Inc. | 2022-10-17 |
| Articaine 4% Versus Lidocaine 2% for Local Anesthesia of MIH-affected Maxillary Molars (NCT05585112) | Latakia University | 2022-10-17 |
| Safe Treatment for Emergency Presentation for Suicidal Ideation and Behavior in Youth (NCT05304065) | University of California, Los Angeles | 2022-10-17 |
| A Study to Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia. (NCT05567458) | Bristol-Myers Squibb | 2022-10-17 |
| The Role of Migraine Prophylaxis Agent Topiramate in Treating Patients With Sudden Sensorineural Hearing Loss (NCT05403229) | Chang Gung Memorial Hospital | 2022-10-17 |
| A Study of Islatravir (MK-8591) in Trans and Gender Diverse Participants (MK-8591-035) (NCT05130086) | Merck Sharp & Dohme LLC | 2022-10-17 |
| Stress Urinary Incontinence Study to Assess Safety and Efficacy of Muvon's Muscle Precursor Cell Therapy (NCT05534269) | University of Zurich | 2022-10-17 |
| Intrathecal Hydromorphone for Postoperative Pain of Anorectal Surgery (NCT05579223) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2022-10-17 |
| 4D-310 in Adults With Fabry Disease and Cardiac Involvement (NCT05629559) | 4D Molecular Therapeutics | 2022-10-16 |
| Study on Human Mass Balance of SPH3127 Tablets (NCT05593562) | Shanghai Pharmaceuticals Holding Co., Ltd | 2022-10-16 |
| Additional Effect of Subthreshold Micropulse Laser to Intravitreous Injection of Bevacizumab on Diabetic Macular Edema (NCT05582577) | Shahid Beheshti University of Medical Sciences | 2022-10-15 |
| Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale (NCT05546320) | Chinese Academy of Medical Sciences, Fuwai Hospital | 2022-10-15 |
| A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis (NCT05402371) | Hepion Pharmaceuticals, Inc. | 2022-10-15 |
| Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study) (NCT04452500) | VA Office of Research and Development | 2022-10-15 |
| Lesion-to-lesion Comparison of 68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG PET/CT in the Evaluation of Metastatic Neuroendocrine Tumors (NCT05255159) | University of Alberta | 2022-10-15 |
| The Study of the Combination of Thiotepa and Pomalidomide for the Treatment of Relapsed/Refractory Primary Central Nervous System Lymphoma Patients. (NCT05931328) | The First Affiliated Hospital with Nanjing Medical University | 2022-10-15 |
| 5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer (NCT05381597) | Boston University | 2022-10-15 |
| A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine SCTV01E-1 in Population Aged Above 18 Years (NCT05522829) | Sinocelltech Ltd. | 2022-10-15 |
| Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation (NCT05511779) | SymBio Pharmaceuticals | 2022-10-14 |
| Osimertinib Therapy After Resection in High-risk Stage I EGFRm NSCLC (OSTAR) (NCT05686434) | Tianjin Medical University Cancer Institute and Hospital | 2022-10-14 |
| Clinical Trial Investigating the Safety and Immunogenicity of GBS6 in Pregnant Women With and Without HIV (PREPARE) (NCT05832502) | St George's, University of London | 2022-10-14 |
| An Open-Label Study of Oral NNZ-2591 in Pitt Hopkins Syndrome (PTHS-001) (NCT05025332) | Neuren Pharmaceuticals Limited | 2022-10-14 |
| A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer (NCT05565378) | GlaxoSmithKline | 2022-10-14 |
| A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE) (NCT05360160) | M.D. Anderson Cancer Center | 2022-10-14 |
| Safety and Efficacy Study of TNX-102 SL in Participants With PTSD (NCT05372887) | Tonix Pharmaceuticals, Inc. | 2022-10-14 |
| Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides (NCT05357794) | M.D. Anderson Cancer Center | 2022-10-13 |